16:49 EDT Mangoceuticals files 16.17M shares of common stock for holders
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MGRX:
- MangoRx Reports 1,685% Increase in Shareholders’ Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024
- Mangoceuticals reports 1H revenue $377,258 vs. $241,959 last year
- Mangoceuticals receives patent in India, initiates clinical trials
- MangoRx Receives Certificate of Grant in India for its Respiratory Illness and Preventive Care Technology Patent
- MangoRx Completes Migration to DEA-Approved Telemedicine Platform, Accelerating Timeline of Oral Dissolvable GLP-1 Weight Loss Treatments Featuring Semaglutide and Tirzepatide